Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,136 | 22,459 | 48,514 | 51,614 | 64,371 |
| Marketable Securities | 1,093 | 929 | 287 | 24,675 | N/A |
| Receivables | 5,546 | 945 | 1,698 | 57 | 3,143 |
| Other current assets | 1,899 | 0 | 0 | 0 | 0 |
| TOTAL | $36,983 | $25,138 | $51,454 | $77,187 | $68,468 |
| Non-Current Assets | |||||
| PPE Net | 241 | 471 | 795 | 1,499 | 2,112 |
| Other Non-Current Assets | 4,988 | 6,582 | 9,281 | 12,597 | 12,821 |
| TOTAL | $5,229 | $7,053 | $10,076 | $14,096 | $14,933 |
| Total Assets | $42,212 | $32,191 | $61,530 | $91,283 | $83,401 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 4,333 | 3,963 | 1,963 | N/A |
| Accounts payable and accrued liabilities | 4,637 | 2,823 | 3,501 | 2,731 | 2,591 |
| Accrued Expenses | 1,611 | 2,908 | 4,137 | 3,554 | 4,620 |
| Other current liabilities | 5,335 | 85 | 2,112 | N/A | 645 |
| TOTAL | $13,494 | $13,689 | $17,081 | $11,548 | $12,788 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 4,202 | 8,035 | N/A |
| Other Non-Current Liabilities | 2,286 | 1,003 | 3,162 | 6,018 | 5,121 |
| TOTAL | $2,286 | $1,003 | $7,364 | $14,053 | $5,121 |
| Total Liabilities | $15,780 | $14,692 | $24,445 | $25,601 | $17,909 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 97,661 | 61,819 | 48,643 | 43,168 | 33,011 |
| Common Shares | 97 | 62 | 47 | 43 | 32 |
| Retained earnings | -368,466 | -341,864 | -301,190 | -250,457 | -197,446 |
| Other shareholders' equity | 0 | 0 | 0 | -96 | 0 |
| TOTAL | $26,432 | $17,499 | $37,085 | $65,682 | $65,492 |
| Total Liabilities And Equity | $42,212 | $32,191 | $61,530 | $91,283 | $83,401 |